Market Cap N/A
Revenue (ttm) 731.78M
Net Income (ttm) 43.64M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 3.44%
Debt to Equity Ratio 1.33
Volume 100
Avg Vol 137
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and con...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 403-777-1519
Address:
1015, 926 – 5 Avenue SW, Calgary, Canada
Montern
Montern Nov. 10 at 12:20 PM
$INNPF Nasdaq getting closer. Should be a good week.
0 · Reply
Montern
Montern Sep. 28 at 9:01 PM
$INNPF Not quite yet. The best place to get in at this point is on the Canadian SE, INNO.CN. Super bullish.
0 · Reply
PhantomAMG
PhantomAMG Sep. 27 at 8:29 AM
$INNPF so now on NASDAQ i think
0 · Reply
PhantomAMG
PhantomAMG Sep. 10 at 6:09 AM
$INNPF now on NASDAQ ?
1 · Reply
musti34
musti34 Aug. 6 at 12:33 PM
$INNPF Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering July 23, 2025 --> available in Q4 probably ?! https://finance.yahoo.com/news/innocan-pharma-announces-public-filing-214700399.html
0 · Reply
MASC73
MASC73 Jul. 30 at 10:05 PM
0 · Reply
Reitenspies
Reitenspies Jul. 24 at 6:26 AM
$INNPF INNOCAN PHARMA CORP. ISIN: CA45783P1027 | WKN: A2PSPW0,1550 € +0,0255 +19,69 % 08:21:42Status: tradeableGeld 0,1500 € Stück: 95.238Brief 0,1600 € Stück: 95.238
1 · Reply
hausschmuck
hausschmuck Jul. 24 at 5:53 AM
$INNPF good news today
0 · Reply
MASC73
MASC73 Jul. 19 at 6:35 PM
$INNPF 12/2025
1 · Reply
Montern
Montern Feb. 24 at 4:58 PM
0 · Reply
Latest News on INNPF
No data available.
Montern
Montern Nov. 10 at 12:20 PM
$INNPF Nasdaq getting closer. Should be a good week.
0 · Reply
Montern
Montern Sep. 28 at 9:01 PM
$INNPF Not quite yet. The best place to get in at this point is on the Canadian SE, INNO.CN. Super bullish.
0 · Reply
PhantomAMG
PhantomAMG Sep. 27 at 8:29 AM
$INNPF so now on NASDAQ i think
0 · Reply
PhantomAMG
PhantomAMG Sep. 10 at 6:09 AM
$INNPF now on NASDAQ ?
1 · Reply
musti34
musti34 Aug. 6 at 12:33 PM
$INNPF Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering July 23, 2025 --> available in Q4 probably ?! https://finance.yahoo.com/news/innocan-pharma-announces-public-filing-214700399.html
0 · Reply
MASC73
MASC73 Jul. 30 at 10:05 PM
0 · Reply
Reitenspies
Reitenspies Jul. 24 at 6:26 AM
$INNPF INNOCAN PHARMA CORP. ISIN: CA45783P1027 | WKN: A2PSPW0,1550 € +0,0255 +19,69 % 08:21:42Status: tradeableGeld 0,1500 € Stück: 95.238Brief 0,1600 € Stück: 95.238
1 · Reply
hausschmuck
hausschmuck Jul. 24 at 5:53 AM
$INNPF good news today
0 · Reply
MASC73
MASC73 Jul. 19 at 6:35 PM
$INNPF 12/2025
1 · Reply
Montern
Montern Feb. 24 at 4:58 PM
0 · Reply
AmazingStockBuyer
AmazingStockBuyer Feb. 19 at 12:34 PM
0 · Reply
hausschmuck
hausschmuck Feb. 19 at 7:23 AM
$INNPF https://www.boerse-express.com/news/articles/innocan-pharma-aktie-mit-schwung-ins-neue-quartal-722125
1 · Reply
Reitenspies
Reitenspies Feb. 19 at 4:44 AM
$INNPF Best regards from Germany. https://www.onvista.de/news/2025/02-18-irw-news-innocan-pharma-corporation-innocan-pharma-erhaelt-fuer-seine-liposomale-cbd-injektion-das-erste-patent-in-indien-0-10-26359904
0 · Reply
Montern
Montern Jan. 26 at 4:56 PM
$INNPF We need the Nasdaq!
1 · Reply
Northern_Lightz
Northern_Lightz Dec. 27 at 4:59 PM
$NRXBF vs. $INNPF: Which is the Best Choice? https://10xalerts.com/nrx-vs-inno-which-is-the-best-choice/
0 · Reply
Medical12
Medical12 Dec. 11 at 1:51 AM
$INNPF https://stockscan.io/stocks/INNPF/forecast INNOCAN PHARMA CORP. Stock (INNPF) Year by Year Forecast INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2025 INNOCAN PHARMA CORP. Stock (INNPF) is expected to reach an average price of $1.5162 in 2025, with a high prediction of $2.1565 and a low estimate of $0.8759. This indicates an +866.95% rise from the last recorded price of $0.1568.
0 · Reply